Wellington Management Group LLP Purchases Shares of 254,673 Bath & Body Works, Inc. (NYSE:BBWI)

Wellington Management Group LLP purchased a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 254,673 shares of the company's stock, valued at approximately $8,129,000. Wellington Management Group LLP owned about 0.12% of Bath & Body Works at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Citizens & Northern Corp boosted its stake in Bath & Body Works by 1.7% in the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company's stock worth $1,151,000 after purchasing an additional 487 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Bath & Body Works by 23.4% during the second quarter. Blue Trust Inc. now owns 2,767 shares of the company's stock valued at $108,000 after buying an additional 524 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Bath & Body Works by 34.4% in the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company's stock valued at $79,000 after acquiring an additional 635 shares during the period. Horizon Bancorp Inc. IN raised its stake in Bath & Body Works by 19.6% in the 2nd quarter. Horizon Bancorp Inc. IN now owns 4,232 shares of the company's stock worth $165,000 after acquiring an additional 695 shares during the last quarter. Finally, Everett Harris & Co. CA lifted its position in Bath & Body Works by 1.5% during the 3rd quarter. Everett Harris & Co. CA now owns 49,140 shares of the company's stock worth $1,569,000 after acquiring an additional 725 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 1.1 %

NYSE:BBWI traded up $0.42 during trading hours on Monday, reaching $38.64. 4,863,334 shares of the company were exchanged, compared to its average volume of 4,020,750. The stock's 50-day moving average is $32.76 and its 200-day moving average is $34.50. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The firm has a market cap of $8.37 billion, a PE ratio of 9.42, a price-to-earnings-growth ratio of 1.44 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.48 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's payout ratio is currently 19.51%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Piper Sandler increased their price objective on Bath & Body Works from $35.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, November 26th. Citigroup cut their price target on shares of Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a report on Tuesday, August 20th. Wells Fargo & Company lifted their price objective on shares of Bath & Body Works from $38.00 to $42.00 and gave the company an "equal weight" rating in a research note on Thursday. The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a "buy" rating on the stock in a report on Thursday, August 29th. Finally, Barclays raised their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $42.50.

Insiders Place Their Bets

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the business's stock in a transaction on Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by insiders.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.